Global Digital Polymerase Chain Reaction Market Likely to Reach USD 312 Million by 2028

The global Digital Polymerase Chain Reaction market size was estimated to be worth roughly USD 143 million in 2021 and is predicted to grow to around USD 312 million by 2028. The global Digital Polymerase Chain Reaction market is predicted to grow at a CAGR of roughly 9.3% during the forecast period.

A laboratory technique called digital PCR is used to make many copies of particular DNA sequences from samples with minimal amounts of DNA. For the purpose of detection, PCR enables the amplification of DNA fragments. Additionally, it is a very accurate and sensitive measurement of nucleic acid. Additionally, it is employed for quantitative and absolute analysis of minority sequences. This PCR technique doesn't rely on measuring sample objectives in terms of quantity.

This kind of PCR, especially when used with materials that contain wild-type sequences, can find uncommon occurrences like single-nucleotide mutation. It is regarded as a vital instrument in patient monitoring, personalized care, diagnostics, cancer investigations, and follow-up administration.

dPCR technological advancements are driving the global digital polymerase chain reaction market growth. The advancement of traditional polymerase chain reaction known as digital polymerase chain reaction allows for the direct quantification and clonal amplification of nucleic acids. Increasing R&D efforts and a rising desire for cutting-edge technology have resulted in the emergence of a number of PCR technologies that offer significant advantages.

Key market participants are predicted to introduce cutting-edge products, such as droplet, chip-based, beam, and crystal devices, to fuel market expansion. For instance, Bio-Rad Laboratories, Inc. announced the release of the QX ONE gadget in November 2019, which offers a more accurate, precise, and sensitive absolute measurement of target DNA molecules. During the predicted period, such technological breakthroughs are anticipated to drive market growth.

The development of the devices has been greatly aided by the switch from droplet-based to chip-based technology for the diagnosis of various diseases. Because the droplets in commercially available droplet dPCR must be manually transferred, the goals are overestimated. Additionally, there is a chance of cross-contamination when using dPCR kits to transfer the material. On the other hand, droplets always move in channels during a chip-based digital polymerase chain reaction, minimizing the possibility of cross-contamination. It is anticipated that this breakthrough will soon be more widely used for disease diagnosis.

However, digital gadgets have many useful applications, but they also have some drawbacks that may prevent widespread market acceptance. Its acceptance may be constrained by some issues, namely the higher price of these digital gadgets in comparison to alternative options. Multiple alternative possibilities are created as a result of this element in the market. For absolute quantification, counting PCR might be used instead of a digital polymerase chain reaction. Gene expressions, copy number variation, and viral load are all quantified.

The global Digital Polymerase Chain Reaction market is segmented based on end-user, application, product type, technology, and region.

Based on end user, the academic & research organizations category is anticipated to grow at a modest CAGR, holding the highest market share. The rising usage of these devices in research studies in numerous sectors, including oncology, genetic illnesses, and others, is credited with the segment's expansion. The category for diagnostics centers is anticipated to grow at the greatest CAGR throughout the forecast period. The expanding use of these digital devices for the diagnosis of various sorts of these diseases and the rising prevalence of infectious diseases are both responsible for the segment's growth.

During the forecast period, the market in Asia Pacific is anticipated to develop at the highest CAGR. The expansion of the market across the region is attributable to the development of the healthcare infrastructure in Asian nations, the high prevalence of infectious and chronic diseases in the area, and the growing awareness of people regarding better treatment outcomes. For instance, approximately 17 lakh persons in India caught HIV in the past ten years, according to information supplied by the National AIDS Control Organization in April 2022 in response to an RTI inquiry. Due to the rising occurrence of infectious diseases in the area, there is a greater need for accurate diagnoses, which is driving the expansion of the Asia Pacific market.

List of prominent players in the global digital polymerase chain reaction market

• STILLA
• JN Medsys
• Formulatrix, Inc
• Fluidigm Corp
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Others         

Recent Developments:

In April 2022, Stilla and Promega Corporation announced their co-marketing agreement that combined sample preparation with the latest Maxwell systems and digital polymerase chain reaction on the six-color Naica system. This collaboration strengthened both companies’ product portfolios.

In March 2022, Stilla announced its partnership with 12 distributors across the EMEA region. With this partnership, the company expanded its presence in the EMEA region.

This review is based on a report by Zion Market Research, titled “Digital Polymerase Chain Reaction Market By Technologies (Droplet Digital PCR, Chip Based Digital PCR, And BEAMing Digital PCR), By Product Type (Digital PCR Systems, Consumables & Reagents, And Software & Services), By Application (Research, Clinical Diagnostics, And Forensic), By End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, And Universities), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.”- Report at https://www.zionmarketresearch.com/report/digital-polymerase-chain-reaction-market

Global digital polymerase chain reaction market is segmented as follows:

By Technology

• Droplet Digital PCR
• Chip Based Digital PCR
• BEAMing Digital PCR

By Product Type

• Digital PCR Systems
• Consumables & Reagents
• Software & Services

By Application

• Research
• Clinical Diagnostics
• Forensic

By End User

• Pharmaceuticals & Biotechnology Industries
• Clinical Diagnostic Laboratories
• Universities

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com